Damora Therapeutics (DMRA) Other Non-Current Assets (2019 - 2026)

Damora Therapeutics' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $34000.0 for Q1 2026.

• Quarterly Other Non-Current Assets fell 89.27% year-over-year to $34000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34000.0 (down 89.27% YoY) and the FY2025 annual result came in at $104000.0, down 36.2% from the prior year.
• Other Non-Current Assets was $34000.0 for Q1 2026 at Damora Therapeutics, down from $104000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.0 million in Q2 2022 and bottomed at $34000.0 in Q1 2026.
• A 5-year average of $1.6 million and a median of $2.0 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets jumped 1320.3% — and 2026, when it plunged 89.27%.
• Damora Therapeutics' Other Non-Current Assets stood at $2.3 million in 2022, then plunged by 50.5% to $1.1 million in 2023, then plunged by 85.55% to $163000.0 in 2024, then sank by 36.2% to $104000.0 in 2025, then slumped by 67.31% to $34000.0 in 2026.
• Business Quant data shows DMRA's Other Non-Current Assets at $34000.0 in Q1 2026, $104000.0 in Q4 2025, and $837000.0 in Q3 2025.